Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Short-term activity ratio | Description | The company |
---|---|---|
Inventory turnover | An activity ratio calculated as cost of goods sold divided by inventory. | Cigna Group inventory turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Receivables turnover | An activity ratio equal to revenue divided by receivables. | Cigna Group receivables turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Payables turnover | An activity ratio calculated as cost of goods sold divided by payables. | Cigna Group payables turnover ratio decreased from 2021 to 2022 and from 2022 to 2023. |
Short-term activity ratio | Description | The company |
---|---|---|
Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Cigna Group number of days of inventory outstanding deteriorated from 2021 to 2022 and from 2022 to 2023. |
Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnover. | Cigna Group number of days of receivables outstanding deteriorated from 2021 to 2022 and from 2022 to 2023. |
Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Cigna Group operating cycle deteriorated from 2021 to 2022 and from 2022 to 2023. |
Average payables payment period | An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. | Cigna Group number of days of payables outstanding increased from 2021 to 2022 and from 2022 to 2023. |
Cash conversion cycle | A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. | Cigna Group cash conversion cycle deteriorated from 2021 to 2022 but then improved from 2022 to 2023 exceeding 2021 level. |
Inventory Turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Pharmacy and other service costs | 133,801) | 124,834) | 117,553) | 103,484) | 97,668) | |
Inventories | 5,645) | 4,777) | 3,722) | 3,165) | 2,661) | |
Short-term Activity Ratio | ||||||
Inventory turnover1 | 23.70 | 26.13 | 31.58 | 32.70 | 36.70 | |
Benchmarks | ||||||
Inventory Turnover, Competitors2 | ||||||
Abbott Laboratories | 2.74 | 3.10 | 3.59 | 2.99 | 3.07 | |
CVS Health Corp. | 16.83 | 14.05 | 13.52 | 11.88 | 12.06 | |
Intuitive Surgical Inc. | 1.96 | 2.27 | 2.98 | 2.49 | 2.30 | |
Medtronic PLC | 2.03 | 2.20 | 2.43 | 2.23 | 2.44 | |
Inventory Turnover, Sector | ||||||
Health Care Equipment & Services | 25.11 | 23.27 | 23.69 | 20.89 | 21.66 | |
Inventory Turnover, Industry | ||||||
Health Care | 10.99 | 10.93 | 10.91 | 9.96 | 10.08 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Inventory turnover = Pharmacy and other service costs ÷ Inventories
= 133,801 ÷ 5,645 = 23.70
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Inventory turnover | An activity ratio calculated as cost of goods sold divided by inventory. | Cigna Group inventory turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Receivables Turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Pharmacy revenues | 137,243) | 128,566) | 121,413) | 107,769) | 103,099) | |
Noninsurance customer receivables | 8,044) | 6,899) | 6,274) | 5,534) | 5,143) | |
Short-term Activity Ratio | ||||||
Receivables turnover1 | 17.06 | 18.64 | 19.35 | 19.47 | 20.05 | |
Benchmarks | ||||||
Receivables Turnover, Competitors2 | ||||||
Abbott Laboratories | 6.11 | 7.02 | 6.64 | 5.40 | 5.88 | |
CVS Health Corp. | 10.12 | 11.79 | 11.91 | 12.32 | 13.04 | |
Elevance Health Inc. | 18.08 | 18.81 | 20.66 | 19.72 | 18.20 | |
Humana Inc. | 51.75 | 55.25 | 45.69 | 66.78 | 60.97 | |
Intuitive Surgical Inc. | 6.30 | 6.60 | 7.30 | 6.75 | 6.94 | |
Medtronic PLC | 5.21 | 5.71 | 5.51 | 6.22 | 4.91 | |
UnitedHealth Group Inc. | 17.27 | 18.22 | 20.07 | 19.86 | 20.32 | |
Receivables Turnover, Sector | ||||||
Health Care Equipment & Services | 13.47 | 14.72 | 14.99 | 15.09 | 14.97 | |
Receivables Turnover, Industry | ||||||
Health Care | 9.03 | 9.77 | 9.45 | 9.50 | 9.90 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Receivables turnover = Pharmacy revenues ÷ Noninsurance customer receivables
= 137,243 ÷ 8,044 = 17.06
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Receivables turnover | An activity ratio equal to revenue divided by receivables. | Cigna Group receivables turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Payables Turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Pharmacy and other service costs | 133,801) | 124,834) | 117,553) | 103,484) | 97,668) | |
Pharmacy and other service costs payable | 19,815) | 17,070) | 15,309) | 13,347) | 10,454) | |
Short-term Activity Ratio | ||||||
Payables turnover1 | 6.75 | 7.31 | 7.68 | 7.75 | 9.34 | |
Benchmarks | ||||||
Payables Turnover, Competitors2 | ||||||
Abbott Laboratories | 4.19 | 4.15 | 4.21 | 3.80 | 4.07 | |
CVS Health Corp. | 20.36 | 18.07 | 19.14 | 19.72 | 20.13 | |
Elevance Health Inc. | 7.72 | 7.47 | 7.59 | 7.75 | 9.25 | |
Humana Inc. | 8.63 | 8.17 | 8.35 | 7.57 | 8.97 | |
Intuitive Surgical Inc. | 12.69 | 13.78 | 14.45 | 18.35 | 11.08 | |
Medtronic PLC | 4.03 | 4.46 | 4.98 | 4.72 | 4.69 | |
UnitedHealth Group Inc. | 7.47 | 7.26 | 7.63 | 7.29 | 7.21 | |
Payables Turnover, Sector | ||||||
Health Care Equipment & Services | 9.17 | 8.91 | 9.25 | 9.16 | 9.95 | |
Payables Turnover, Industry | ||||||
Health Care | 7.85 | 7.55 | 7.68 | 7.52 | 8.05 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Payables turnover = Pharmacy and other service costs ÷ Pharmacy and other service costs payable
= 133,801 ÷ 19,815 = 6.75
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Payables turnover | An activity ratio calculated as cost of goods sold divided by payables. | Cigna Group payables turnover ratio decreased from 2021 to 2022 and from 2022 to 2023. |
Working Capital Turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Current assets | 37,351) | 30,120) | 36,134) | 27,799) | 29,845) | |
Less: Current liabilities | 48,716) | 41,229) | 43,572) | 36,022) | 40,138) | |
Working capital | (11,365) | (11,109) | (7,438) | (8,223) | (10,293) | |
Pharmacy revenues | 137,243) | 128,566) | 121,413) | 107,769) | 103,099) | |
Short-term Activity Ratio | ||||||
Working capital turnover1 | — | — | — | — | — | |
Benchmarks | ||||||
Working Capital Turnover, Competitors2 | ||||||
Abbott Laboratories | 4.54 | 4.48 | 3.87 | 4.06 | 6.64 | |
CVS Health Corp. | — | — | — | — | — | |
Elevance Health Inc. | 7.83 | 8.37 | 7.23 | 6.39 | 6.11 | |
Humana Inc. | 9.47 | 10.27 | 8.67 | 7.42 | 7.19 | |
Intuitive Surgical Inc. | 1.14 | 1.29 | 1.22 | 0.77 | 1.23 | |
Medtronic PLC | 2.47 | 2.97 | 2.15 | 2.48 | 2.26 | |
UnitedHealth Group Inc. | — | — | — | — | — | |
Working Capital Turnover, Sector | ||||||
Health Care Equipment & Services | 86.58 | 72.82 | 40.87 | 44.34 | 59.48 | |
Working Capital Turnover, Industry | ||||||
Health Care | 20.20 | 18.71 | 13.72 | 14.03 | 9.09 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Working capital turnover = Pharmacy revenues ÷ Working capital
= 137,243 ÷ -11,365 = —
2 Click competitor name to see calculations.
Average Inventory Processing Period
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data | ||||||
Inventory turnover | 23.70 | 26.13 | 31.58 | 32.70 | 36.70 | |
Short-term Activity Ratio (no. days) | ||||||
Average inventory processing period1 | 15 | 14 | 12 | 11 | 10 | |
Benchmarks (no. days) | ||||||
Average Inventory Processing Period, Competitors2 | ||||||
Abbott Laboratories | 133 | 118 | 102 | 122 | 119 | |
CVS Health Corp. | 22 | 26 | 27 | 31 | 30 | |
Intuitive Surgical Inc. | 186 | 161 | 122 | 147 | 159 | |
Medtronic PLC | 180 | 166 | 150 | 164 | 150 | |
Average Inventory Processing Period, Sector | ||||||
Health Care Equipment & Services | 15 | 16 | 15 | 17 | 17 | |
Average Inventory Processing Period, Industry | ||||||
Health Care | 33 | 33 | 33 | 37 | 36 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 23.70 = 15
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Average inventory processing period | An activity ratio equal to the number of days in the period divided by inventory turnover over the period. | Cigna Group number of days of inventory outstanding deteriorated from 2021 to 2022 and from 2022 to 2023. |
Average Receivable Collection Period
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data | ||||||
Receivables turnover | 17.06 | 18.64 | 19.35 | 19.47 | 20.05 | |
Short-term Activity Ratio (no. days) | ||||||
Average receivable collection period1 | 21 | 20 | 19 | 19 | 18 | |
Benchmarks (no. days) | ||||||
Average Receivable Collection Period, Competitors2 | ||||||
Abbott Laboratories | 60 | 52 | 55 | 68 | 62 | |
CVS Health Corp. | 36 | 31 | 31 | 30 | 28 | |
Elevance Health Inc. | 20 | 19 | 18 | 19 | 20 | |
Humana Inc. | 7 | 7 | 8 | 5 | 6 | |
Intuitive Surgical Inc. | 58 | 55 | 50 | 54 | 53 | |
Medtronic PLC | 70 | 64 | 66 | 59 | 74 | |
UnitedHealth Group Inc. | 21 | 20 | 18 | 18 | 18 | |
Average Receivable Collection Period, Sector | ||||||
Health Care Equipment & Services | 27 | 25 | 24 | 24 | 24 | |
Average Receivable Collection Period, Industry | ||||||
Health Care | 40 | 37 | 39 | 38 | 37 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 17.06 = 21
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Average receivable collection period | An activity ratio equal to the number of days in the period divided by receivables turnover. | Cigna Group number of days of receivables outstanding deteriorated from 2021 to 2022 and from 2022 to 2023. |
Operating Cycle
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data | ||||||
Average inventory processing period | 15 | 14 | 12 | 11 | 10 | |
Average receivable collection period | 21 | 20 | 19 | 19 | 18 | |
Short-term Activity Ratio | ||||||
Operating cycle1 | 36 | 34 | 31 | 30 | 28 | |
Benchmarks | ||||||
Operating Cycle, Competitors2 | ||||||
Abbott Laboratories | 193 | 170 | 157 | 190 | 181 | |
CVS Health Corp. | 58 | 57 | 58 | 61 | 58 | |
Intuitive Surgical Inc. | 244 | 216 | 172 | 201 | 212 | |
Medtronic PLC | 250 | 230 | 216 | 223 | 224 | |
Operating Cycle, Sector | ||||||
Health Care Equipment & Services | 42 | 41 | 39 | 41 | 41 | |
Operating Cycle, Industry | ||||||
Health Care | 73 | 70 | 72 | 75 | 73 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 15 + 21 = 36
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Operating cycle | Equal to average inventory processing period plus average receivables collection period. | Cigna Group operating cycle deteriorated from 2021 to 2022 and from 2022 to 2023. |
Average Payables Payment Period
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data | ||||||
Payables turnover | 6.75 | 7.31 | 7.68 | 7.75 | 9.34 | |
Short-term Activity Ratio (no. days) | ||||||
Average payables payment period1 | 54 | 50 | 48 | 47 | 39 | |
Benchmarks (no. days) | ||||||
Average Payables Payment Period, Competitors2 | ||||||
Abbott Laboratories | 87 | 88 | 87 | 96 | 90 | |
CVS Health Corp. | 18 | 20 | 19 | 19 | 18 | |
Elevance Health Inc. | 47 | 49 | 48 | 47 | 39 | |
Humana Inc. | 42 | 45 | 44 | 48 | 41 | |
Intuitive Surgical Inc. | 29 | 26 | 25 | 20 | 33 | |
Medtronic PLC | 91 | 82 | 73 | 77 | 78 | |
UnitedHealth Group Inc. | 49 | 50 | 48 | 50 | 51 | |
Average Payables Payment Period, Sector | ||||||
Health Care Equipment & Services | 40 | 41 | 39 | 40 | 37 | |
Average Payables Payment Period, Industry | ||||||
Health Care | 46 | 48 | 48 | 49 | 45 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 6.75 = 54
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Average payables payment period | An estimate of the average number of days it takes a company to pay its suppliers; equal to the number of days in the period divided by payables turnover ratio for the period. | Cigna Group number of days of payables outstanding increased from 2021 to 2022 and from 2022 to 2023. |
Cash Conversion Cycle
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data | ||||||
Average inventory processing period | 15 | 14 | 12 | 11 | 10 | |
Average receivable collection period | 21 | 20 | 19 | 19 | 18 | |
Average payables payment period | 54 | 50 | 48 | 47 | 39 | |
Short-term Activity Ratio | ||||||
Cash conversion cycle1 | -18 | -16 | -17 | -17 | -11 | |
Benchmarks | ||||||
Cash Conversion Cycle, Competitors2 | ||||||
Abbott Laboratories | 106 | 82 | 70 | 94 | 91 | |
CVS Health Corp. | 40 | 37 | 39 | 42 | 40 | |
Intuitive Surgical Inc. | 215 | 190 | 147 | 181 | 179 | |
Medtronic PLC | 159 | 148 | 143 | 146 | 146 | |
Cash Conversion Cycle, Sector | ||||||
Health Care Equipment & Services | 2 | 0 | 0 | 1 | 4 | |
Cash Conversion Cycle, Industry | ||||||
Health Care | 27 | 22 | 24 | 26 | 28 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 15 + 21 – 54 = -18
2 Click competitor name to see calculations.
Short-term activity ratio | Description | The company |
---|---|---|
Cash conversion cycle | A financial metric that measures the length of time required for a company to convert cash invested in its operations to cash received as a result of its operations; equal to average inventory processing period plus average receivables collection period minus average payables payment period. | Cigna Group cash conversion cycle deteriorated from 2021 to 2022 but then improved from 2022 to 2023 exceeding 2021 level. |